Impact of the COVID-19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 27 04 2020
accepted: 05 05 2020
pubmed: 18 5 2020
medline: 25 2 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

The healthcare burden posed by the coronavirus disease 2019 (COVID-19) pandemic in the New York Metropolitan area has necessitated the postponement of elective procedures resulting in a marked reduction in cardiac catheterization laboratory (CCL) volumes with a potential to impact interventional cardiology (IC) fellowship training. We conducted a web-based survey sent electronically to 21 Accreditation Council for Graduate Medical Education accredited IC fellowship program directors (PDs) and their respective fellows. Fourteen programs (67%) responded to the survey and all acknowledged a significant decrease in CCL procedural volumes. More than half of the PDs reported part of their CCL being converted to inpatient units and IC fellows being redeployed to COVID-19 related duties. More than two-thirds of PDs believed that the COVID-19 pandemic would have a moderate (57%) or severe (14%) adverse impact on IC fellowship training, and 21% of the PDs expected their current fellows' average percutaneous coronary intervention (PCI) volume to be below 250. Of 25 IC fellow respondents, 95% expressed concern that the pandemic would have a moderate (72%) or severe (24%) adverse impact on their fellowship training, and nearly one-fourth of fellows reported performing fewer than 250 PCIs as of March 1st. Finally, roughly one-third of PDs and IC fellows felt that there should be consideration of an extension of fellowship training or a period of early career mentorship after fellowship. The COVID-19 pandemic has caused a significant reduction in CCL procedural volumes that is impacting IC fellowship training in the NY metropolitan area. These results should inform professional societies and accreditation bodies to offer tailored opportunities for remediation of affected trainees.

Sections du résumé

BACKGROUND
The healthcare burden posed by the coronavirus disease 2019 (COVID-19) pandemic in the New York Metropolitan area has necessitated the postponement of elective procedures resulting in a marked reduction in cardiac catheterization laboratory (CCL) volumes with a potential to impact interventional cardiology (IC) fellowship training.
METHODS
We conducted a web-based survey sent electronically to 21 Accreditation Council for Graduate Medical Education accredited IC fellowship program directors (PDs) and their respective fellows.
RESULTS
Fourteen programs (67%) responded to the survey and all acknowledged a significant decrease in CCL procedural volumes. More than half of the PDs reported part of their CCL being converted to inpatient units and IC fellows being redeployed to COVID-19 related duties. More than two-thirds of PDs believed that the COVID-19 pandemic would have a moderate (57%) or severe (14%) adverse impact on IC fellowship training, and 21% of the PDs expected their current fellows' average percutaneous coronary intervention (PCI) volume to be below 250. Of 25 IC fellow respondents, 95% expressed concern that the pandemic would have a moderate (72%) or severe (24%) adverse impact on their fellowship training, and nearly one-fourth of fellows reported performing fewer than 250 PCIs as of March 1st. Finally, roughly one-third of PDs and IC fellows felt that there should be consideration of an extension of fellowship training or a period of early career mentorship after fellowship.
CONCLUSIONS
The COVID-19 pandemic has caused a significant reduction in CCL procedural volumes that is impacting IC fellowship training in the NY metropolitan area. These results should inform professional societies and accreditation bodies to offer tailored opportunities for remediation of affected trainees.

Identifiants

pubmed: 32415916
doi: 10.1002/ccd.28977
pmc: PMC7276744
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

201-205

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL146982
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals, Inc.

Références

J Am Coll Cardiol. 2015 May 5;65(17):1844-53
pubmed: 25777641
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):201-205
pubmed: 32415916
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375
pubmed: 32199938
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):586-597
pubmed: 32212409

Auteurs

Tanush Gupta (T)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Tamim M Nazif (TM)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Torsten P Vahl (TP)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Hasan Ahmad (H)

Westchester Medical Center, Valhalla, New York, USA.

Anna E Bortnick (AE)

Montefiore Medical Center, Bronx, New York, USA.

Frederick Feit (F)

NYU Langone Health, New York, New York, USA.

Rajiv Jauhar (R)

Northshore University Hospital, Northwell Health, Manhasset, New York, USA.

Ruben Kandov (R)

Staten Island University Hospital, New York, New York, USA.

Michael Kim (M)

Lennox Hill Hospital, New York, New York, USA.

Annapoorna Kini (A)

Mount Sinai Medical Center, New York, New York, USA.

William Lawson (W)

Stony Brook University Hospital, Stony Brook, New York, USA.

Robert Leber (R)

Mount Sinai Morningside Hospital, New York, New York, USA.

Alexander Lee (A)

Long Island Jewish Medical Center, New Hyde Park, New York, USA.

Abel E Moreyra (AE)

Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.

Robert M Minutello (RM)

New York-Presbyterian Hospital/Weil Cornell Medical Center, New York, New York, USA.

Terrence Sacchi (T)

New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, USA.

Pranaychan J Vaidya (PJ)

Hackensack University Medical Center, Hackensack, New Jersey, USA.

Martin B Leon (MB)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Sahil A Parikh (SA)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Ajay J Kirtane (AJ)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Susheel Kodali (S)

New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH